COVID-19 mortality risk among women with ovarian cancer: a matched case-control study
Women with ovarian cancer are immunocompromised any additional disease will have a significant impact. This retrospective study from Brazil looks at the risk of death for women with ovarian cancer who are infected with the COVID-19 virus.
During the period 2020-2024, data was collected for 474 patients with ovarian cancer and compared to 1896 controls without ovarian cancer. Both groups had severe COVID-19 infections with Severe Adult Respiratory Syndrome. The ovarian cancer cases were matched for other comorbidities.
Results from the study showed significantly higher mortality, with more than 2.5 times the risk of death for women with ovarian cancer who developed COVID-19. Encouragingly, the death rate was greatly reduced (by 65%) for those women who had been completely vaccinated.
The authors suggest early intervention with antiviral treatment is mandatory for these women and stress the importance of booster vaccination for the latest COVID-19 subtypes.
.jpeg)
No comments:
Post a Comment